Skip to content

Prevalence of 3-OMD Elevation and AADC Deficiency in a Group of Cerebral Palsy-Like Patients of Unknown Cause

Epidemiological Study of 3-OMD Elevation and AADC Deficiency in a Cerebral Palsy-like Patient Population - Frequency of AADC Deficiency in Cerebral Palsy-like Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000054976
Enrollment
40
Registered
2024-07-16
Start date
2024-08-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AADC Deficiency

Interventions

When a patient who is the subject of the study is seen, the materials will be used by the principal investigator/associate investigator to explain the disease AADC deficiency and the significance of t
Application Form Checklist&quot
below) should be checked and mailed together with the filter paper blood. The Jichi Medical University Department of Pediatrics will measure the 3-OMD and make a decision as to whether it is normal or

Sponsors

Jichi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: With any of the following symptoms: Abnormal Ocular Seizures (Also called Oculogyric Crisis, in which the eyeballs are fixed in vertical, abducted, or adducted positions, sometimes with tension or abnormal posture. They occur in paroxysms every few days, lasting from a few minutes to several hours.) decreased muscle tone: Abnormal movement: dystonia, athetosis, little movement Ptosis, diurnal fluctuations in physical condition, which recover after sleep Sleep disturbances: excessive sleep, insomnia Psychiatric symptoms: Easily stimulated, mood swings Autonomic symptoms: Hyperhidrosis, drooling, nasal obstruction, diarrhea or constipation, temperature dysregulation Hypoglycemic attacks

Exclusion criteria

Exclusion criteria: Risk factors for cerebral palsy (prematurity, low birth weight, multiple births, low blood sugar, jaundice/nucleus pulposus, parenthood, intracranial hemorrhage, infection, stroke, head injury, etc.)

Design outcomes

Primary

MeasureTime frame
prevalence of AADC deficiency, prevalence of elevated 3-OMD

Secondary

MeasureTime frame
validity as a screening test

Countries

Japan

Contacts

Public ContactHitoshi Osaka

Jichi Medical University Department of Pediatrics

hosaka@jichi.ac.jp0285587366

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026